Berlex Laboratories Inc, Subsidiary of Schering AG
Product management roles for flagship brands culminating in Executive Director of Marketing, Berlex Laboratories, Inc., 1983-1993. Launched $200M anti-arrhythmic product, Betapace and gained 6% in market share with OC line of products. Re-launched MRI agent Magnevist generating $100M per year in sales
Drug Regulatory Affairs, responsibilities included advertising and promotion, NDA/ANDA strategy and development, clinical development and manufacturing.